HDAC8-IN-14
HDAC8-IN-14, a curcuminoid derivative, is a selective HDAC8 inhibitor with a Ki of 9 nM. HDAC8-IN-14 induces the production of reactive oxygen species (ROS), disrupts mitochondrial membrane potential, and promotes apoptosis. HDAC8-IN-14 can significantly promote the accumulation of cells in the sub-G0/G1 phase, consistent with apoptotic or necrotic cell death. HDAC8-IN-14 induces upregulation of cytochrome c, cleaved caspase-3, and the pro-apoptotic protein Bak while leaving the anti-apoptotic Bcl-2 levels unaltered. HDAC8-IN-14 can be used for the study of leukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C37H27Cl2N5O
- 分子量:628.55
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Caspase アイソフォーム固有の製品をすべて表示
More
生物活性
|
HDAC8 9 nM (Ki) |
Caspase-3 |
HDAC8-IN-14 (Compound 5e) (0.1-100 μM, 48 h) exhibits a low IC50 value of 90 nM in MOLT-4 cells, along with IC50 values of 1.98 μM in EL-4, 1.17 μM in YAC-1, and 18.94 μM in L1210 cells, while demonstrating a significantly higher IC50 of 39.20 μM in the non-cancerous HEK-293 cell line, indicating its selectivity and safety toward non-cancerous cells at effective concentrations[1].
HDAC8-IN-14 (100 nM, 30 min) shows significant ROS induction as measured by the fluorescent dye H2DCFDA (HY-D0940) in MOLT-4 cells[1].
HDAC8-IN-14 (48 h) induces mitochondrial depolarization, evidenced by a shift in JC-1 fluorescence, triggers both apoptosis (~ 10 %) and necrosis (~ 30 %), and causes cell cycle arrest characterized by a 20 % increase in the sub-G0 apoptotic population alongside a reduction in G0/G1 and G2/M phases and a slight S-phase accumulation[1].
HDAC8-IN-14 (50-100 nM, 48 h) induces a significant upregulation of cytochrome c, cleaved caspase-3, and the pro-apoptotic protein Bak while leaving the anti-apoptotic Bcl-2 levels unaltered, indicating that it activates the intrinsic apoptotic pathway through a Bcl-2-independent mechanism in MOLT-4 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MOLT-4 cells
-
Concentration:50 nM, 100 nM
-
Incubation Time:48 h
-
Result:Induced a significant upregulation of cytochrome c, cleaved caspase-3, and the pro-apoptotic protein Bak while leaving the anti-apoptotic Bcl-2 levels unaltered.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:The left thigh of each female Swiss albino mice (6-8 weeks) was injected with 0.5 million DLA cells to induce a tumor[1].
-
Dosage:50 mg/kg
-
Administration:I.p., once daily for 30 days
-
Result:Reduced tumor burden compared to the control group.
Resulted in the upregulation of cytochrome c, cleaved caspase 3, and proapoptotic Bax, the levels of the anti-apoptotic Bcl-2 remained unchanged.
Exhibited reduced nuclear density, suggesting decreased tumor cell proliferation.
No significant histopathological alterations were observed in the liver and kidney tissues of treated mice.
Indicated no toxicity to liver function.
The body weight of the animals at the end of the study showed no variation.
化学情報
-
分子量 628.55
-
分子式 C37H27Cl2N5O
-
SMILES
O=C1/C(CNC/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(Cl)C=C4)=C/C5=CN(C6=CC=CC=C6)N=C5C7=CC=C(Cl)C=C7
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
HDAC8-IN-14 関連分類
HY-178380 関連分類
Powered by Bioz